Montis Biosciences SRL
8.2 FTEMontis Biosciences reported total assets of €2.97m at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jul 2026), with 8.2 full-time equivalents.
By total assets for 2025, Montis Biosciences ranks among the 200 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Montis Biosciences shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -64 % Headcount (avg FTE) -20 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Montis Biosciences's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 20 Jul 2023
- Year ended 31 Dec 2021filed on 24 Oct 2022
Montis Biosciences's financial analysis
- Solvency-168.9%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Montis Biosciences
Montis Biosciences's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0730.979.429
- VAT number
- BE0730979429
- Peppol
- Registered · 0208:0730979429 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Jul 2019
- Registered office
- 3001 Leuven
- Size
- Micro · 8.2 FTE
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Montis Biosciences (SRL) has been based in Leuven since 2019, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of €3.23m and equity of −€5.01m; its revenue is not published. With 8.2 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -168.9%, below the median of its sector (60.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Montis Biosciences
Companies in the same business, of comparable size and area, outside its group.
- NanoBiotech Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 1,834 €
- Pacira Belgium Research and experimental development on natural sciences and engineering Eupen · balance sheet €3.00m
- Elmace Research and experimental development on natural sciences and engineering Aalter · balance sheet €3.11m
- Dr. J. Bellon Research and experimental development on natural sciences and engineering Buggenhout · balance sheet €3.14m
- Dr. G. Degraeve, Psychiater Research and experimental development on natural sciences and engineering Maldegem · balance sheet €2.56m
- ImmuneSpec Research and experimental development on natural sciences and engineering Niel · balance sheet €3.54m
- K5 Therapeutics Research and experimental development on natural sciences and engineering Leuven · balance sheet €3.56m
- Envitec Measurements and Analytics SA Research and experimental development on natural sciences and engineering Gembloux · balance sheet €3.64m
Frequently asked questions about Montis Biosciences
What is the revenue of Montis Biosciences?
Montis Biosciences files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Montis Biosciences?
In Belgium, the VAT number is the company number prefixed with BE: BE0730979429 for Montis Biosciences, if the company is VAT-registered. Its company number (CBE) is 0730.979.429.
Where is the registered office of Montis Biosciences?
According to the CBE register, the registered office of Montis Biosciences is in 3001 Leuven.
What is the equity of Montis Biosciences?
At the close of the 2025 financial year, the equity of Montis Biosciences amounts to -5,008,958 €, a solvency of -168.9% of total assets.
How many people work at Montis Biosciences?
8.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Montis Biosciences?
The register lists 7 active mandates at Montis Biosciences. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Montis Biosciences within its sector?
By total assets for 2025, Montis Biosciences ranks among the 200 largest of the 993 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.
The full file of Montis Biosciences
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →